CDC

The annual accounts of CDC for financial year 2025 show a net loss of 60% of the equity at the start of that year. The 2025 annual accounts show equity of €10,865 and a net result of -€16,260. Equity is growing by about 13% per year across the filed financial years. Its solvency ranks better than 24% of 9,617 sector peers (NACE 82, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.6% (low).